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Effect of reactive oxygen species on endothelin.1 production by human
mesangial cells. Reactive oxygen species (ROS) have been implicated in
the pathophysiology of renal ischemia/reperfusion injury. Endothelin-1
(ET-1) is generated in abundance in renal ischemia/reperfusion with
resultant decreases in renal blood flow and glomerular filtration rate. To
determine if ROS regulate ET-1 production, the effect of ROS donors or
scavengers on ET-1 protein and mRNA levels in cultured human mesang-
ial cells was examined. Incubation with xanthine/xanthine oxidase, glucose
oxidase, or H202 caused a dose-dependent rise in ET-1 release. Similarly,
xanthine/xanthine oxidase or H202 augmented ET-1 mRNA levels. In
contrast, the ROS scavengers dimethylthiourea (DMTU), dimethylpyrro-
line N-oxide, or pyrrolidine dithiocarbamate reduced basal ET-1 release,
while DMTU lowered ET-1 mRNA levels. Deferoxamine, an iron chela-
tor, also decreased basal ET-1 release. Superoxide dismutase potentiated
the ET-1 stimulatory effect of xanthine/xanthine oxidase, while catalase
abrogated the effect of xanthine/xanthine oxidase and H202. The effects of
ROS were unrelated to changes in nitric oxide production or cytotoxicity.
These data indicate that exogenously or endogenously-derived ROS can
increase ET-1 production by human mesangial cells. While superoxide
anion reduces ET-1 levels, H202 leads to enhanced production of the
peptide. ROS stimulation of mesangial cell ET-1 production may contrib-
ute to impaired glomerular hemodynamics in the setting of renal ischemia/
reperfusion injury.
Ischemia/reperfusion of the kidney is associated with prolonged
vasoconstriction that can prevent or delay functional renal recov-
ery [11. Among the vasoactive factors implicated in this process,
endothelin-1 (ET-1), the most potent vasoconstrictor known [21,
has emerged as art important pathologic mediator. Tissue ET-1
expression is enhanced, sometimes for days, following ischemia/
reperfusion of the kidney [3, 4] and other organ systems [5, 6].
Specific anti-ET-1 antibodies or endothelin receptor antagonists
are markedly protective against decrements in renal blood flow
and glomerular filtration rate following renal ischemia [3, 7—il] as
well as improving tissue perfusion post-ischemia in other vascular
beds [12]. The mechanism(s) by which ischemia/reperfusion stim-
ulates ET-1 production are, however, largely unknown. Hypoxia
can augment endothelial cell ET-1 release [13, 14] and has been
shown to acutely elevate endogenous renal ET-1 content [15].
However, hypoxia fails to explain both the increase in renal ET-1
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production and the prolonged nature (up to days) of the aug-
mented renal ET-1 production following restoration of blood flow
[4, 10]. While there is no evidence to clearly implicate specific
ET-1 stimulating factor(s) that arise during reperfusion, the
temporal relationship between oxygen radical and ET-1 produc-
tion raises the possibility that the two events may be related.
Reperfusion is associated with a rapid and prolonged increase in
renal oxygen radical production [1, 16, 17]. While conflicting data
exist, numerous studies have demonstrated that oxygen radical
scavengers protect against reperfusion injury of the kidney [1].
One mechanism by which oxygen radicals may contribute to renal
dysfunction is through altering the balance of vasoactive factors
such that an excessive vasoconstricting influence prevails. For
example, superoxide anion (02) can break down nitric oxide
[18], resulting in diminished vasodilation [19, 20]. Oxygen radicals
can also stimulate glomerular eicosanoid [21] and possibly plate-
let-activating factor (PAF) [22] production by the renal glomeru-
lus. The effect of oxygen radicals on ET-1 production is, however,
largely unknown. Hence, we undertook the current study to
determine if oxygen radicals can modify renal cell ET-1 produc-
tion.
This investigation utilizes the glomerular mesangial cell to
examine the role of oxygen radicals in regulating ET-1 production.
Mesangial cells are modified smooth muscle cells and, due to their
contractile ability and central location in the glomerulus, can
modulate glomerular filtration rate and renal blood flow. Mesang-
ial cells produce ET-1 [23] which can act in an autocrine manner
to elicit mesangial cell contraction [24]. In addition, mesangial
cells produce oxygen radicals [22], which can, in turn, increase
mesangial cell prostaglandin, thromboxane, and PAF release [22].
In the current study, the effect of oxygen radical donors and
scavengers on cultured human mesangial cell ET-1 release and
mRNA levels is examined.
Methods
Mesangial cell culture
Renal cortex was obtained from four human nephrectomies
performed at the University of Utah Hospital for renal cell
carcinoma. The cortex was minced and sequentially filtered
through 60, 70 and 100 mesh sieves. The glomeruli retained on the
100 mesh sieve were collected, aspirated several times through a
25 gauge needle to disrupt glomerular capsules, and digested in 2
mglml collagenase (Type IV, Sigma Chemical Co., St. Louis, MO,
USA) in Krebs buffer for 15 to 30 minutes at 37°C. Glomerular
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fragments were centrifuged, plated onto 75 cm2 Corning culture
flasks in RPMI supplemented with 20% fetal bovine serum, 2 m
glutamine, 100 U/mi penicillin/streptomycin, and 60 U/rn! human
insulin (hereafter referred to as mesangial cell media) and grown
at 37°C in a 5% CO2 environment. All cells were studied at
confluence between passages 4 to 9. As previously described by
this laboratory, the cultures after the second passage exhibit
typical mesangial cell morphology, stain uniformly positive for
smooth muscle myosin, and do not stain for factor Vill-related
antigen [23].
Effect of oxygen radical donors or scavengers on ET-1 release
Mesangial cells in 24 well plates were exposed to oxygen radical
donors and/or scavengers in 300 d mesangial cell media either
without serum (for 1 to 6 hr) or with 20% serum (for 12 to 72 hr)
at 37°C in a 5% CO2 environment. Serum was added when
studying longer time points since ET-1 production drops to nearly
undetectable levels when mesangial cells are serum-deprived for
more than 12 hours (unpublished observation). The oxygen
radical scavengers included 0.1 to 10 mrvi dimethyithiourea
(DMTU) (Aldrich, Milwaukee, WI, USA), 50 JIM pyrrolidine
dithiocarbamate (PDTC), 50 mvt 5,5-dimethyl-1-pyrolline N-ox-
ide (DMPO) (Aldrich), and the iron chelator, deferoxamine (1
mM). Hydrogen peroxide (H202) was supplied either directly (10
to 1000 jIM) or through the interaction of glucose oxidase (Ito 10
mU/ml) and media glucose. Superoxide anion, H202, and hy-
droxyl radical (0H) were generated by xanthine oxidase (0.1 to 20
mU/ml) in the presence of 0.1 m'vi xanthine. In some experiments,
superoxide dismutase (SOD, 500 U/mi) or catalase (2000 U/mi,
Calbiochem, La Jolla, CA, USA) were added alone or at the same
time as glucose oxidase or xanthine/xanthine oxidase (XXO). At
the end of the incubation, supernatant was removed for determi-
nation of ET-1 content and the cells solubilized in 0.1 N NaOH.
An aiiquot of NaOH was mixed with Bradford reagent (Bio-Rad,
Richmond, CA, USA) and protein concentration determined by
measuring absorbance at 590 nm [25]. All results are expressed as
pg ET-1/mg total cell protein.
Measurement of immunoreactive ET-]
Each 300 l sample was dried in a Speed-Vac and suspended in
100 jxl RIA buffer. ET-1 was measured using a kit purchased from
Peninsula Laboratories, Inc. (Belmont, CA, USA) and as previ-
ously described by this laboratory [26]. The lower limit of sensi-
tivity for ET-1 detection was 2 pg. Intraassay variation was less
than 9%; interassay variation was less than 15%. Competitive
binding inhibition curves for ET-1 antibody showed less than 5%
cross reactivity with unlabeled ET-3 and less than 3% cross
reactivity with unlabeled ET-2. Reactivity with big endothelin has
not been evaluated.
Effect of oxygen radical donors or scavengers on ET-1 mRNA
Mesangial cells on 6 well plates were incubated with mesangial
cell media alone or containing 10 rntvt DMTU, 250 jIM H2O2, or I
mU/mi xanthine oxidase/0.1 mM xanthine for six hours at 37°C in
a 5% CO2 environment. Cells were then overlaid with 4 M
guanidinium thiocyanate, 25 rns sodium citrate, 1% f3-mercapto-
ethanol, and 1% sarcosyl (pH 7.0). RNA was phenol/chloroform
extracted and quantified spectrophotometrically. A semiquantita-
tive PCR method was employed for determination of ET-1
mRNA levels as previously described [261. Five micrograms of
total RNA from each sample was reverse transcribed by incubat-
ing with 250 pmol random hexamers (Boehringer Mannheim,
Indianapolis, IN, USA), 4 mM MgC12, 400 U murine Moloney
Leukemia Virus reverse transcriptase (Gibco BRL, Grand Island,
NY, USA), 80 U RNAsin (Promega, Madison, WI, USA), 500 jIM
deoxynucleotide triphosphates (dNTP, Perkin-Elmer, Norwalk,
CT, USA), 1 mivi dithiothreitol, 50 mM KC1, 10 mM Tris-Cl, and
0.01% gelatin (final buffer pH 8.3) in 50 jxl for one hour at 37°C.
The reverse transcriptase was inactivated by heating for 10
minutes at 94°C. The resultant eDNA was amplified by poly-
merase chain reaction. Each sample was measured for ET-1 and
/3-actin eDNA in separate tubes using specific primers. The
upstream and downstream primers for ET-1 were GCTGTTTGT-
GGITFGCCAAGGAGC and TGCTCGGTTGTGGGTCACAT
AACG, respectively. These yielded a single 600 base pair frag-
ment which, when cycle sequenced with fluoresceinated primer
ends (performed by Margaret Robinson in Dr. Ray White's
laboratory at the University of Utah), proved identical to positions
30 to 630 in human ET-1 eDNA [27]. PCR of human genomic
DNA using these primers did not yield a product as predicted
since these primers span several introns [28]. The upstream and
downstream primers for /3-actin were TGGAGAAGAGCTAT-
GAGCTGCCTG and GTGCCACCAGACAGCACTGTGTTG,
respectively, which yielded a 201 base pair eDNA fragment. PCR
of genomic DNA yielded a 289 base pair product that is comple-
mentary to position 2499—2788 in the /3-actin gene, confirming
that this primer set also spans an intron. PCR was performed by
incubating 5 1d (approximately 0.4 jIg) of sample eDNA with 50
mM KCI, 10 ifiM Tris-Cl, 0.01% gelatin, 1.5 mrvi MgCl2, 2.5%
formamide, 2 U Taq polymerase (Boehringer), 200 JIM each
dNTP, 100 pmoles of 13-actin or ET-I primers, and 0.1 JICi
32PdCTP (Amersham, Arlington Heights, IL, USA) in 50 jIl final
volume (final pH 8.3 at room temperature). PCR using 13-actin
and ET-1 primers were carried out for 25 or 35 cycles, respec-
tively, using a Perkin-Elmer Cetus 9600 Gene-Amp System; this
number of cycles result in samples being obtained during the
exponential phase of amplification. ET-1 and f3-actin primers
were never combined in the same tube. Twenty microliters of the
final PCR reaction was electrophoresed on a 7% non-denaturing
polyaciylamide gel. Gels were stained with ethidium bromide and
the bands corresponding to the eDNA product were excised,
mixed with scintillation cocktail, and cpm determined on a
Beckman beta counter.
ET-1 and 13-actin eDNA obtained from PCR of reverse tran-
scribed RNA were used to generate standard curves. The eDNA
was amplified by PCR, the resultant amplified product divided
into small fractions that were, in turn, re-amplified. After removal
of primers using Magic PCR Prep (Promega), the purity of the
final product was confirmed by electrophoresis. At the end of the
purification, the amount of standard eDNA was quantitated
spectrophotometricaliy. Standard curves for /3-actin or ET-I were
made by simultaneously amplifying sample eDNA and, in separate
tubes, standard eDNA (10_i to 10 ng/tube). Every PCR
amplification included a standard curve. All PCR consisted of
simultaneous amplification (in separate tubes) of eDNA for ET-1
and f3-actin. All results are expressed as ag ET-1 eDNA/pg /3-actin
eDNA in order to control for the amount of RNA initially reverse
transcribed. The accuracy of this semiquantitative PCR technique
has been previously described in detail [26, 29].
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Determination of nitrite levels
Mesangial cells in 24 well plates were exposed to mesangial cell
media alone or containing H202 (100 to 1000 /.tM) or xanthine
oxidase (0.1 to 10 mU/ml in 0.1 mrvi xanthine) for one to six hours
at 37°C in a 5% CO2 environment (N = 8 each condition).
Following incubation, duplicate 50 tl aliquots of the supernatants
were removed and immediately tested for nitrite (NO2—) levels
(stable breakdown product of NO) as previously described [30].
To each aliquot, 100 x1 of Greiss Reagent (1% sulfanilamide in
30% acetic acid and 0.1% N-(1-naphthyl)ethylenediamine dihy-
drochioride in 60% acetic acid in a 1:1 mixture) was added and
mixed for one minute. Absorbance at 550 nm was immediately
measured in a Thermomax microplate reader (Molecular Devices
Corp., Menlo Park, CA, USA). N02 levels were determined by
comparing sample values with a standard curve established with
known quantities of sodium nitrite. The cells were solubilized with
0.1 N NaOH and total protein determined as described above.
Determination of cGMP levels
Mesangial cells in 24 well plates were preincubated in 0.1 mM
isobutylmethylxanthine (IBMX) for 30 minutes, followed by ex-
posure to mesangial cell media with IBMX alone or containing 10
mM DMTU, 50 .LM PDTC, 1 m'vi deferoxamine, 500 fLM H202, or
2 mU/mI xanthine oxidase/0.1 mrvi xanthine for 10 minutes or six
hours at 37°C in a 5% CO2 environment (N = 8 each condition).
The cells were treated with 100% ethanol overnight, the ethanol
evaporated, the samples resuspended in assay buffer and cGMP
determined using a commercially available radioimmunoassay
(Amersham). The cell protein was solubilized with 0.1 N NaOFI
and total cell protein determined as described above.
Determination of 51Cr release
Mesangial cells in 24 well plates were incubated with 1 Ci/m1
51Cr (Amersham) in mesangial cell media for 24 hours. The cells
were then rinsed four times with mesangial cell media and
incubated with mesangial cell media alone or containing 0.1 to 20
M xanthine oxidase in 0.1 mM xanthine, 10 to 1000 xM 11202, or
ito 10 mM DMTU for six hours at 37°C in a 5% CO2 environment
(N = 5 to 6 each condition). Radioactivity (cpm) that had been
released (supernatant) or remained intracellular (0.1 N NaOH
solubilized cells) was measured by scintillation counting. 51Cr
release was determined by dividing cpm in the supernatant by
total cpm (supernatant + intracellular).
Statistics
All data were compared by analysis of variance. Results are
expressed as mean SEM. P values < 0.05 were taken as
significant.
Materials
All chemicals and reagents were obtained from Sigma Chemical
Co. unless otherwise stated.
Results
Effect of oxygen radical donors on ET-1 production by human
mesangial cells
Addition of H202 directly (Fig. 1) or generated by glucose
oxidase/glucose (Fig. 2A) for six hours resulted in dose-dependent
stimulation of ET-1 release by human mesangial cells. The ET-1
stimulatory effect of glucose oxidase was due to initial generation
of H202 since catalase (converts H202 to water and oxygen)
completely abrogated glucose oxidase action, while catalase given
alone did not change ET-1 release (Fig. 2B). H202 also aug-
mented ET-1 mRNA levels in mesangial cells (Fig. 3). Increasing
the doses of glucose oxidase (up to 20 mU/mi) or 11202 (up to 10
mM) did not have an added stimulatory effect on ET-i production.
The ET-1 stimulating effect of H202 occurred at concentrations
well below those that caused cytotoxicity, as evidenced by no
change in 51Cr release, trypan blue uptake, or total cell protein,
until concentrations of 500 xM H202 were reached (Fig. 4B). All
experiments were performed for not less than six hours since we
were unable to consistently detect measurable amounts of ET-i
for shorter incubation periods. Exposure to 250 .LM H202 for up
to 72 hours did not cause significant cytotoxicity and continued to
stimulate ET-1 production by two- to threefold over control
values (data not shown). To facilitate initial characterization of
the effects of ROS donors and scavengers on mesangial cell ET-1
production, the current studies focused on the six-hour time
period.
To examine the effect of XXO products (02, H202, and 0H)
on ET-1 release, mesangial cells were incubated with XXO for six
hours. As shown in Figure 5A, XXO caused a dose-dependent
stimulation of ET-1 release. Additionally, exposure to XXO for
six hours increased ET-1 mRNA levels (Fig. 3). In contrast to
H2O2, XXO stimulation of ET-1 release occurred at concentra-
tions that were cytotoxic as evidenced by an increase in 51Cr
release (Fig. 4A). Further, exposure to xanthine oxidase at
concentrations down to 0.5 mU/mi for 12 to 72 hours caused
significant cell detachment, thereby making data analysis prob-
lematic. When the dose of xanthine oxidase was lowered to the
point where no cell detachment occurred (0.1 mU/mi), no change
in ET-1 production was detected at 12 or 24 hours.
The above data suggested that the stimulatory effect of XXO on
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Fig. 1. Effect of hydrogen peroxide on ET-1 release by cultured human
mesangial cells. Cells were incubated with 10 to 250 jxM H2O2 for six hours
and the supernatant analyzed for ET-1. N = 6each data point. *p < 0.001
versus control.
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Fig. 2. Effect of glucose oxidase on ET-1 release by cultured human
mesangial cells. A. Cells were incubated with I to 10 mU/mi glucose
oxidase for six hours and the supernatant analyzed for ET-1. N = 6 each
data point. < 0.01, P < 0.001; both versus control. B. Cells were
incubated for six hours with 2000 U/mI catalase (CAT), 5 mU/mi glucose
oxidase (GO), or 2000 U/mI catalase + mU/ml glucose oxidasc
(GO+CAT). N = 4 each data point. #p < 0.025 versus control and versus
GO + CAT.
mesangial cell ET-1 release may be related, at least in part, to cell
toxicity. One possibility is that XXO disruption of the plasma
membrane, and release of cytoplasmic ET-1, explained the in-
crease in ET-1 release. To test this, mesangial cells were incu-
bated with media alone for six hours and, at the end of the
incubation, half the cells were lysed by removal of the media and
adding water for 15 minutes (N = 6 each group). ET-1 content
was determined in the media from control cells as well as in the
combination of the removed media and the water from lyzed cells.
ET-1 levels were similar in the two groups (12.1 0.1 pg ET-1/mg
protein in controls and 11.1 0.1 pg ET-1/mg protein in lyzed
cells). In another experiment, ET-1 content was determined in the
water alone after a 15 minute treatment of the cells (N = 6)
without combining the water with the media. No ET-1 was
detectable in the water despite visually-confirmed cell lysis. These
results therefore indicate that cell lysis does not release stored
ET-1, and are consistent with previous reports failing to identify
significant intracellular pools of ET-1 [31].
A concern with the above data was the finding that 1 mU/mi
xanthine oxidase stimulated ET-1 mRNA accumulation, but had
no detectable effect of ET-1 release (Figs. 3 and 5A). One
potential explanation was that one or more of the ROS generated
by XXO reduced ET-1 stability and/or immunoreactivity; ET-1
has a carboxy terminus tryptophan that is highly susceptible to
oxidation, To examine this, 1-1202 or XXO were added to mesang-
ial cell media that contained 8 pg of synthetic ET-1 (Peninsula),
and incubated in test tubes (in the absence of any cells) for six
hours at 37°C in a 5% CO2 environment. As shown in Figure 6A,
up to 1000 /.LM H202 had no effect on ET-1 immunoreactivity. In
contrast, 20 mU/ml xanthine oxidase in the presence of 0.1 mM
xanthine caused a marked reduction in ET-1 immunoreactivity.
Decrements in ET-1 immunoreactivity could be seen at concen-
trations of xanthine oxidase as low as 1 mU/mi. Xanthine oxidase
(20 mU/mi) without xanthine did not affect ET-1 stability (Fig.
6B), indicating that potentially contaminating proteases were not
causing ET-1 degradation. In addition, incubation of mesangial
cells for six hours with 20 mU/mi xanthine oxidase alone (without
xanthine) had no effect on ET-1 release (data not shown). Since
H2O2 did not alter FT-i stability, these data suggested that °2
was responsible for reduced ET-1 levels. To test this, XXO was
added to mesangial cell media (in the absence of cells) that
contained 4 pg of synthetic ET-1 in the presence and absence of
500 U/mI superoxide dismutase (SOD; converts 02 to H202)
and incubated as described above. As shown in Figure 6B, SOD
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10 Fig. 3. Effect of 10 mM DMTU, 250 p.*t H202, or 1 mU/mi xanthine
oxidase/0.1 mMxanthine on ET-1 mRNA in cultured human mesangial cells.
All reagents were incubated with cells for six hours and RNA levels
determined by reverse transcription and polymerase chain reaction (see
Methods). N = 3 each data point. *p < 0.05 versus control.
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Fig. 4. Effect of ROS on 51Cr release by cultured human mesangial cells.
Cells were incubated with 0.1 to 20 mU/mI xanthine oxidase in the
presence of 0.1 mrvi xanthine (A) or 100 to 1000 jLM 11202 (B) for six hours
and 51Cr release determined as described in the Methods. N = 5 to 6 each substantially greater than that detected by radioimmunoassay. To
data point. #p < 0.05, *t'p < 0.005, *P < 0.001; all versus control, further test this, mesangial cells were incubated with XXO in the
presence or absence of 500 U/ml SOD. As shown in Figure 5B,
SOD either uncovered (1 mU/mi xanthine oxidase) or potentiated
markedly preserved ET-1 immunoreactivity in the presence of 10 (10 mU/mi xanthine oxidase) a stimulatory effect of XXO on ET-1
mU/mi xanthine oxidase and xanthine. These data suggest that release. Hence, 02 generated by XXO appears to interact with
°2 interferes with detection of ET-1 and that the actual amount the ET-1 peptide to reduce its immunoreactivity; whether it
of ET-1 released by cells exposed to 02 may have been reduces its bioactivity remains to be determined.
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Fig. 6. Effect of ROS on ET-J immunoreactivity. A. H202 or xanthine
oxidase/0.1 msi xanthine (XO) were added to media spiked with 8 pg of
FT-i and incubated in test tubes (without cells) for six hours at 37°C. N =
6 each data point. *jD < 0.001 versus control. B. 10 mU/mi xanthine
oxidase alone (XO) or together with 0.1 mM xanthine (XXO) in the
presence or absence of 500 U/mI superoxide dismutase (SOD) was added
to media spiked with 4 pg of ET-1 and incubated as described above. N =
4 each data point. *P < 0.001 versus control; **P < 0.001 versus XXO and
P < 0.005 versus control.
Since SOD potentiated XXO action and since H202 stimulated
ET-1 production, the hypothesis was tested that the ET-1 stimu-
latoiy action of XXO was related to H202 generation. As
illustrated in Figure 7, catalase prevented augmented ET-1 re-
lease in response to XXO, supporting the notion that H202 is the
mediator, or is a necessary intermediary, of XXO-stimulated ET-1
release by mesangial cells.
Effect of oxygen radical scavengers on ET-1 release by human
mesangial cells
Addition of the oxygen radical scavenger DMTU [32] to
mesangial cells for six hours caused a dose-dependent decrease in
basal ET-1 release (Fig. 8). Further support for an inhibitory
effect of DMTU was provided by the finding that this compound
markedly reduced ET-1 mRNA levels in mesangial cells (Fig. 3).
DMTU had no effect on 51Cr release, trypan blue exclusion, or
total cell protein (data not shown). DMPO and PDTC, two other
oxygen radical scavengers [32, 33], also inhibited basal ET-1
release (Fig. 9), indicating that the response was not idiosyncratic
for DMTU. Deferoxamine, which inhibits oxygen radical forma-
tion by chelating iron, also reduced basal ET-1 release (Fig. 9).
Taken together, these data indicate that, in cultured human
mesangial cells, basal oxygen radical levels, are sufficient to
tonically elevate ET-1 release.
Effect of oxygen radicals on nitric oxide and cGMP levels in
human mesangial cells
Nitric oxide (NO) has been shown to inhibit ET-1 production by
a number of cell types, including mesangial cells [31]. Since
superoxide anion can breakdown NO [18], the effect of H202 or
xanthine/xanthine oxidase on this system was examined. No nitrite
was detected after six hours of incubation with media alone or
containing 100 to 1000 1.LM H202 or 0.1 to 10 mU/mi xanthine
oxidase in the presence of 0.1 mrvi xanthine (N = 8 each
condition). To further examine a role for NO, mesangial cells
were exposed to the above concentrations of H202 or 02 in the
presence of 0.5 mvt NGmonomethylLarginine monacetate (L-
NMMA, Chem-Biochem Research, Salt Lake City, UT, USA), an
inhibitor of NO production [30]. L-NMMA alone or in the
presence of ROS had no effect on basal or stimulated ET-1
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Fig. 7. Effect of 2000 U/mI catalase (CAT) and 10 mU/mi xanthine
oxidase/0. 1 mac xanthine (XXO) on ET-] release by cultured human
mesangial cells. Cells were incubated with reagents for six hours and
supernatant analyzed for FT-i. N = 4 each data point. *J.) < 0.005 versus
control and P < 0.01 versus catalase alone.
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Fig. 8. Effect of 0.1 to 10 mst dimethylthiourea (DMTU) on basal ET-l
release by cultured human mesangial cells. Cells were incubated with
DMTU for six hours and the supernatant analyzed for ET-1. N = 6 each
data point. < 0.005, P < 0.001; both versus control.
production, respectively. Cyclic GMP accumulation was also
measured since this nucleotide mediates NO inhibition of ET-1
production [34]. Mesangial cells incubated with 10 mivt DMTU, 50
xM PDTC, 1 mivi deferoxamine, 500 xM H202, or 0.1 m'i
xanthine/2 mU/mi xanthine oxidase (all in the presence of IBMX)
for 10 minutes or six hours had no significant difference in cGMP
accumulation (N = 8 each condition, data not shown). Hence,
oxygen radical regulation of mesangial cell ET-1 production is not
due to modification of NO or cGMP levels.
Discussion
Oxygen radicals may be important modulators of renal blood
flow and glomerular filtration rate. ROS are formed during
reperfusion following ischemia [1, 16, 17] and, by virtue of the
protective effects of various oxygen radical scavengers, have been
implicated in ischemia/reperfusion injury of the kidney [1, 35].
Oxygen radicals may promote vascular smooth muscle and me-
sangial cell contraction by several mechanisms. For example, O2
combines with NO to produce peroxynitrite [18], thereby reducing
NO-mediated vasodilation [19, 201. O2 constricts isolated canine
cerebral arteries [36], and has been implicated in re-oxygenation
contraction of rat aortic rings [37]. O2 and H202 elicit mesangial
cell contraction which is mediated, at least in part, by PAF [381. In
addition, oxygen radicals stimulate isolated glomeruli to release
various eicosanoids, including thromboxane B2 [21]. In this study,
we describe another mechanism by which ROS could reduce renal
blood flow and glomerular filtration rate: stimulation of ET-1
production.
The current study demonstrates that exogenous ROS increase
ET-1 release by, and ET-1 mRNA levels in, cultured human
mesangial cells. Further, evidence is provided that oxygen radical
scavengers reduce basal ET-1 production by mesangial cells,
indicating that endogenous oxygen radicals can tonically stimulate
ET-1 synthesis and release. These findings are in agreement with
a preliminary report in which four hours of exposure to XXO or
H202 increased ET-1 mRNA levels in bovine aortic endothelial
cells (ET-1 release was not assessed) [39]. Another brief report
noted that neither exogenous O2 nor H2O2 altered basal ET-1
release by bovine pulmonary artery endothelial cells [40]. This
group did find that exogenous hydroxyl radical (OW) caused a
two- to threefold increase in endothelial cell ET-1 release, but
only at OW concentrations that elicited cell damage; ET-1 mRNA
levels were not measured and the effects of oxygen radical
scavengers on ET-1 production were not evaluated. Finally,
extremely high concentrations of H202 (up to 20 mM) have been
reported to reduce ET-1 release by human umbilical vein endo-
thelial cells; however, the significance of this observation is
uncertain [41]. Unfortunately, detailed investigations on the ef-
fects of oxygen radical donors and scavengers on ET-1 release and
mRNA levels in endothelial cells have not been performed; such
studies are clearly needed.
The mechanism of oxygen radical stimulation of ET-1 release
by mesangial cells remains speculative. As mentioned earlier, a
reduction in NO levels could theoretically reduce NO-inhibited
ET-1 production [181. We found no evidence for oxygen radical
modification of NO release. Furthermore, cGMP, which mediates
NO inhibition of ET-1 production [341, was not altered by oxygen
radicals. Disruption of the cell membrane with release of stored
ET-1 was another possible mechanism of oxygen radical action;
however, our results, as well as those of others, indicate that cells
do not contain measurable intracellular pools of the peptide [311.
Oxygen radicals could stimulate mesangial cell ET-1 production
through augmenting thromboxane levels [42]; however, this has
not been evaluated, An interesting possibility is that the transcrip-
tion factor, nuclear factor-KB (NF-KB), could be involved in
mediating oxygen radical effects. NF-B has been demonstrated
to regulate the transcription of a variety of genes [43], and is
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Fig. 9. Effect of oxygen radical scavengers on basal ET-1 release by cultured
human mesangial cells. Cells were incubated with 50 ms 5,5-dimethyl-1-
pyroline N-oxide (DMPO), 50 M pyrolidine dithiocarbamate (PDTC), or
1 mM deferoxamine (DFO) for six hours and the supernatant analyzed for
ET-1. N = 6 each data point. < 0.025, *P < 0.001; both versus control.
DMPO PDTC DFO
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augmented by reactive oxygen intermediates [44] and inhibited by
oxygen radical scavengers [45]. 02 increases mesangial cell
nuclear NF-KB levels [461. Our analysis of the human ET-1
promoter reveals four consensus recognition motifs for NF-KB
binding located 2 to 3 kb 5' to the transcription start site. It
remains to be determined if NF-iB regulates ET-1 gene expres-
sion; this is an area in need of further investigation.
The precise species of reactive oxygen compounds or precur-
sors that mediate stimulation of ET-1 release by human mesangial
cells has yet to be fully determined. H202 appears to be at least an
essential intermediate in the process since catalase completely
destroys the ET-1 stimulatosy action of XXO. °2 primarily
reduced immunoreactive ET-1 levels in the cell supernatants since
superoxide dismutase enhanced the ET-1 stimulatory action of
XXO. This effect of O2 was related, at least in part, to a direct
inhibitory effect of 02 on ET-1 immunoreactivity since XXO,
but not xanthine oxidase, reduced ET-1 immunoreactivity in a
cell-free system. The current study did not examine the means by
which O2 induced decreases in ET-1 immunoreactivity, however,
there is a basis for speculation as to at least one probable
mechanism. As discussed earlier, O2 could oxidize the carboxy
terminal tryptophan. If this occurred, then not only ET-1 immu-
noreactivity, but also bioactivity, could be reduced [71 Interest-
ingly, one group has reported that hydroxyl radicals, generated by
electrical field stimulation of porcine coronary artery strips,
reduced both the contractile effect of exogenous ET-1 and the
concentration of immunoreactive ET-1 [48]. These considerations
raise the question as to what is the net effect of oxygen radicals on
ET-1 production by mesangial cells. Clearly, H2O2, which does
not modify ET-1 immunoreactivity directly, augments ET-1
mRNA levels and ET-1 production by the cell. This may be
negated in part by 02 induced structural modification of the
peptide. The finding that oxygen radical scavengers consistently
reduce mesangial cell ET-1 release suggests, however, that the net
effect of oxygen radicals is to stimulate ET-1 production.
The interaction between ET-1 and oxygen radicals may be even
more complex than alluded to above; this interaction may also
pertain to conditions other than ischemia/reperfusion injury. For
example, ET-1 can stimulate oxygen radical production by neu-
trophils [49] and rat lung [50], thereby potentially establishing a
positive feedback system that could exacerbate tissue injury.
Inflammatory cytokines such as tumor necrosis factor (TNF)
increase oxygen radical production by mesangial cells [51] as well
as augmenting mesangial cell ET-1 release [23]. Interestingly,
oxygen radicals appear to function as second messengers in
mediating various cellular effects of TNF [31, raising the possi-
bility that they may be involved in mediating, at least in part, TNF
stimulation of the production of ET-1, and possibly other sub-
stances, in the kidney.
In summary, the current study constitutes the first report that
oxygen radicals have a net stimulatory effect on ET-1 production
by human mesangial cells. In addition, evidence is provided that
basal endogenous oxygen radicals tonically regulate ET-1 produc-
tion. The interaction between oxygen radicals and ET-1 may
represent a mechanism that contributes to the pathophysiology of
renal ischemia/reperfusion injury. The role of this system in
modifying reoxygenation injury to the kidney, as well as other
vascular beds, is in need of further investigation.
Acknowledgements
This work was supported in part by Merit Review and Career Devel-
opment Awards from the Department of Veterans Affairs and by National
Institutes of Health grant R29 DK44440 (all to D.E.K.).
Reprint requests to Donald E. Kohan, MD., Ph.D., Division of Nephrology
and Hypertension, University of Utah Medical Center, Salt Lake City, Utah
84132, USA.
References
1. GREENE EL, PALLER MS: Oxygen free radicals in acute renal failure.
Miner Electrol Metab 17:124—132, 1991
2. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M,
MITSUI Y, YAZAKI Y, GoTo K, MASAKI T: A novel potent vasocon-
strictor peptide produced by vascular endothelial cells. Nature 332:
411—415, 1988
3. Mmo N, KOBAYASHI M, NAKAJIMA A, AMANO H, SHIMAMOTO K,
ISHIKAWA K, WATANABE K, NISHIKIBE M, Y.r4o M, IKEMOTO F:
Protective effect of a selective endothelin receptor antagonist, BQ-
123, in ischemic acute renal failure in rats. EurJPharmacol 221:77—83,
1992
4. FIRTH JD, RATCLIFFE PJ: Organ distribution of the three rat endo-
thelin messenger RNAs and the effects of ischemia on renal gene
expression. J Clin Invest 90:1023-1031, 1992
5. VELASCO CE, TURNER M, INAGAMI T, ATKINSON JB, VIRMANI R,
JACKSON EK, MURRAY JJ, FORMAN MB: Reperfusion enhances the
local release of endothelin after regional myocardial ischemia. Am
HeartJ 128:441—451, 1994
6. YEGEN C, AKTAN AU, BUYUKGEBIZ 0, HAKLAR G, YALIN R, ERcAN
S: Effect of verapamil and illoprost (ZK36374) on endothelin release
after mesenteric ischemia-reperfusion injury. Eur Surg Res 26:69—75,
1994
7. CH.N L, CHITTINANDANA A, SHAPIRO JI, SHANLEY PF, SCHRIER RW:
Effect of an endothelin-receptor antagonist on ischemic acute renal
failure. Am J Physiol 266:F135—F138, 1994
8. GELLAI M, JUGUS M, FLETCHER T, DEWOLF R, NAMBI P: Reversal of
postischemic acute renal failure with a selective endothelin A receptor
antagonist in the rat. J Clin Invest 93:900—906, 1994
9. LOpEz-FE A, GOMEZ-GARRE D, BERNABEU F, LOPEZ-NOVOA JM:
A role for endothelin in the maintenance of post-ischaemic renal
failure in the rat. J Physiol 444:513-522, 1991
10. KON V, YOSHIOKA T, Focio A, ICF{IKAwA I: Glomerular actions of
endothelin in vivo. J Clin Invest 83:1762—1767, 1989
11. STINGO AT, CLAVELL AL, AARHUS LL, BURNETT JCJ: Biological role
for the endothelin-A receptor in aortic cross-clamping. Hypertension
22:62—66, 1993
12. HASDAI D, KORNOWSKI R, BATTLER A: Endothelin and myocardial
ischemia. Cardiovasc Drug Ther 8:589—599, 1994
13. KOUREMBANAS S, MARSDEN PA, MCQUILLAN LP, FALLER DV: Hy-
poxia induces endothelin gene expression and secretion in cultured
human endothelium. J Cliii Invest 88:1054—1057, 1991
14. HIEDA HS, GOMEZ-SANCHEZ CE: Hypoxia increases endothelin re-
lease in bovine endothelial cells in culture, but epinephrine, norepi-
nephrine, serotonin, histamine and angiotensin II do not. Life Sci
47:247—251, 1990
15. NIR A, CLAVELL AL, HEUBLEIN D, AARHUS LL, BURNETT JCJ: Acute
hypoxia and endogenous renal endothelin. JAm Soc Nephrol 4:1920—
1924, 1994
16. NILS50N UA, HARALDSSON G, RATELL S, SORENSEN V, AKERLUND S,
PETrERSSON S, SCHERSTEN T, JONSSON 0: ESR-measurement of
oxygen radicals in vivo after renal ischaemia in the rabbit. Effects of
pretreatment with superoxide dismutase and heparin. Acta Physiol
Scand 147:263—270, 1993
17. GONZALEZ-FLECHA B, EVELSON P, STERIN-SPEZIALE N, BOVERIS A:
Hydrogen peroxide metabolism and oxidative stress in cortical, med-
ullary and papillary zones of rat kidney. Biochim Biophys Acta
1157:155—161, 1993
18. GRYGLEWSKI RJ, PALMER RMJ, MONCADA S: Superoxide anion is
involved in the breakdown of endothelium-derived vascular relaxing
factor. Nature 320:454—456, 1986
Hughes et al: Oxygen radicals and ET-1 in mesangial cells 189
19. SECCOMBE JF, PEARSON PJ, SCHAFF HV: Oxygen radical-mediated
vascular injury selectively inhibits receptor-dependent release of nitric
oxide from canine coronary arteries. J Thorac Cardiovasc Surg 107:
505—509, 1994
20. DOWELL Fl, HAMILTON CA, MCMURRAY J, REID J: Effects of a
xanthine oxidase/hypoxanthine free radical and reactive oxygen spe-
cies generating system on endothelial function in New Zealand white
rabbit aortic rings. J Cardiovasc Swg 22:792—797, 1993
21. BAUD L, NIVEZ M-P, CHANSEL D, ARDAILLOU R: Stimulation by
oxygen radicals of prostaglandin production by rat renal glomeruli.
Kidney mt 20:332—339, 1981
22. BAUD L, FOUQUERAY B, PHILLIPPE C, ARDAILLOU R: Reactive oxygen
species as glomerular autacoids. JAm Soc Nephrol 2:S132—S138, 1992
23. KofLr'l DE: Production of endothelin-1 by rat mesangial cells:
Regulation by tumor necrosis factor. J Lab Cliii Med 119:477—484,
1992
24. SIM0N50N M, DUNN MJ: Endothelin-1 stimulates contraction of rat
glomerular mesangial cells and potentiates /3-adrenergic-mediated
cyclic adenosine monophosphate accumulation. J Clin Invest 85:790—
797, 1990
25. BRADFORD MM: A rapid and sensitive method for quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding. Anal Biochem 72:248—254, 1976
26. Koiwi DE, PADILLA E: Osmolar regulation of endothelin-1 produc-
tion by rat inner medullary collecting duct. J Clin In vest 91:1235—1240,
1993
27. ITOH Y, YANAGISAWA M, OHKUBO S, KIMURA C, KOSAKA T, IN0UE A,
ISHIDA N, MITSUI Y, ONDA H, FUJINO F, MASAKI T: Cloning and
sequence analysis of eDNA encoding the precursor of human endo-
thelium-derived vasoconstrictor peptide, endothelin: Identity of hu-
man and porcine endothelin. FEBS Lett 231:440—444, 1988
28. BLOCI-I KD, FRIEDRICH P, LEE M, EDDY RL, SHows TB, QUERTER-
MOUS T: Structural organization and chromosomal assignment of the
gene encoding endothelin. J Biol Chem 264:10851—10857, 1989
29. HUGHES AK, CLINE RC, KOHAN DE: Alterations in renal endothelin
production in the spontaneously hypertensive rat. Hypertension 20:
666—673, 1992
30. MARKEWITZ BA, MICHAEL JR, KORAN DE: Cytokine-induced expres-
sion of a nitric oxide synthase in rat renal tubule cells. J Clin Invest
91:2138—2143, 1993
31. KORAN DE: Endothelins in the kidney: Physiology and pathophysiol-
ogy. Am J Kid Dis 22:493—5 10, 1993
32. VAIwI J, TAYLOR CG, RISER B, SHUMAKER DK, YEH K-Y, DAME M,
GIBBS DF, TODD RF, DUMLER F, BROMBERG J, KILLEN PD: Mesangial
cell killing by leukocytes: Role of leukocyte oxidants and proteolytic
enzymes. Kidney mt 42:1169—1177, 1992
33. SCHENK H, KLEIN M, ERDBRUGGER W, DROGE W, SCHULZE-OSTHOFF
K: Distinct effects of thioredoxin and antioxidants on the activation of
transcription factors NF-KB and AP-1. Proc Natl Acad Sci USA
91:1672—1676, 1994
34. BOULANGER C, LUSCHER TF: Release of endothelin from the porcine
aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest
85:587—590, 1990
35. ANDREOLI SP: Reactive oxygen molecules, oxidant injury and renal
disease. Pediatr Nephrol 5:733—742, 1991
36. KATUSIC ZS, VANHOUTFE PM: Superoxide anion is an endothelium-
derived contracting factor. Am J Physiol (Heart Circ Physiol 26)
257:H33—H37, 1989
37. MEHTA JL, LAWSON DL, YANG BC, HAUGHT WH, HINTZE T: Role of
superoxide radicals in anoxia and reoxygenation-mediated vascular
contraction. Life Sci 49:1739—1746, 1991
38. DUQUE I, GARCfA-ESCRIBANO C, RODRfGUEZ-PUYOL M, DfEz-
MARQUES ML, LOPEZ-NOVOA JM, ARRIBAS I, HERNANDO L, Ro-
DRfGUEz-PuyoL D: Effects of reactive oxygen species on cultured rat
mesangial cells and isolated rat glomeruli. Am J Physiol 263:F466—
F473, 1992
39. RODRfGUEZ-PUYOL D, LOPEZ-ONGIL 5, Lucio J, LAMAS 5, Ruiz P,
RODRfGUEZ-PUYOL M: Modulation of pre-pro-endothelin and consti-
tutive nitric oxide synthase mRNA expression by reactive oxygen
species in bovine aortic endothelial cells. (abstract) JAm Soc Nephrol
5:590, 1994
40. PRASAD MR, JONES RM, KREUTZER DL: Release of endothelin from
cultured bovine endothelial cells. J Mol Cell Cardiol 23:655—658, 1991
41. MITCHELL MD, BRANCH DW, LAMARCHE 5, DUDLEY DJ: The regu-
lation of endothelin production in human umbilical vein endothelial
cells: Unique inhibitory action of calcium ionophores. J Clin Endocri-
nol Metab 75:665—668, 1992
42. ZOJA CSO, PERICO N, BENIGNI A, MORIGI M, BENA1-rI L, RAMBALDI
A, REMUZZI G: Constitutive expression of endothelin gene in cultured
human mesangial cells and its modulation by transforming growth
factor-13, thrombin, and a throniboxane A2 analogue. Lab Invest
64:16—20, 1991
43. MARUI N, OFFERMANN MK, SWERLICK R, KUNSCH C, ROSEN CA,
AHMAD M, ALEXANDER RW, MEDFORD RM: Vascular cell adhesion
molecule-i (VCAM-1) gene transcription and expression are regu-
lated through an antioxidant-sensitive mechanism in human vascular
endothelial cells. J Clin Invest 92:1866—1874, 1993
44. SCHRECK R, RIEBER P, BAEUERLE PA: Reactive oxygen intermediates
as apparently widely used messengers in the activation of the NF-KB
transcription factor and HIV-1. EMBO J 10:2247—2258, 1991
45. SCHRECK R, MEIER B, MANNEL DN, DROGE W, BAEUERLE PA:
Dithiocarbamates as potent inhibitors of nuclear factor KB activation
in intact cells. J Exp Med 175:1181—1194, 1992
46. SATRIANO 1, SCHLONDORFF D: Activation and attenuation of tran-
scription factor NF-KB in mouse glomerular mesangial cells in re-
sponse to tumor necrosis factor-a, immunoglobulin G, and adenosine
3':S'-cyclic monophosphate. J Clin Invest 94:1629—1636, 1994
47. KIMURA 5, KASUYA Y, SAWAMURA T, SHINMI 0, SUGITA Y, YANAGI-
SAWA M, GoTo K, MASAKI T: Structure-activity relationships of
endothelin: Importance of the C-terminal moiety. Biochem Biophys
Res Commun 156:1182—1186, 1988
48. YASUDA N, KASUYA Y, YAMADA G, HAM AH, MASAKI T, GOTO K:
Loss of contractile activity of endothelin-1 induced by electrical field
stimulation-generated free radicals. Br J Pharmacol 113:21—28, 1994
49. ISHIDA K, TAKESHIGE K, MINAKAMI 5: Endothelin-l enhances super-
oxide generation of human neutrophils stimulated by the chemotactic
peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem Biophys
Res Commun 173:496—500, 1990
50. NAGASE T, FUKUCHI Y, Jo C, TERAMOTO 5, UEJIMA Y, ISHIDA K,
SHIMIZU T, ORIM0 H: Endothelin-1 stimulates arachidonate 15-
lipoxygenase activity and oxygen radical formation in the rat distal
lung. Biochem Biophys Res Commun 168:485—489, 1990
51. RADEKE HH, MEJER B, TOPLEY N, FLOEGE J, HABERMEHL GG,
RESCH K: Interleukin 1-a and tumor necrosis factor-a induce oxygen
radical production in mesangial cells. Kidney Irn 37:767—775, 1990
